rs267607263
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM4_SupportingPP5_Very_Strong
The NM_002437.5(MPV17):c.263_265delAGA(p.Lys88del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000867 in 1,614,054 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_002437.5 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPV17 | NM_002437.5 | c.263_265delAGA | p.Lys88del | disruptive_inframe_deletion | Exon 4 of 8 | ENST00000380044.6 | NP_002428.1 | |
MPV17 | XM_005264326.5 | c.263_265delAGA | p.Lys88del | disruptive_inframe_deletion | Exon 4 of 8 | XP_005264383.1 | ||
MPV17 | XM_017004151.2 | c.215_217delAGA | p.Lys72del | disruptive_inframe_deletion | Exon 4 of 8 | XP_016859640.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251478Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135914
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461870Hom.: 0 AF XY: 0.00000550 AC XY: 4AN XY: 727238
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74340
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This variant, c.263_265del, results in the deletion of 1 amino acid(s) of the MPV17 protein (p.Lys88del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs267607263, gnomAD 0.004%). This variant has been observed in individual(s) with mitochondrial DNA depletion syndrome (PMID: 17694548, 29282788; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 38352). This variant disrupts the p.Lys88 amino acid residue in MPV17. Other variant(s) that disrupt this residue have been observed in individuals with MPV17-related conditions (PMID: 20074988), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
In-frame deletion of 1 amino acid(s) in a non-repeat region; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 20074988, 19748572, 31980526, 34052969, 37184518, 35598585, 29282788, 17694548) -
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) Pathogenic:2
This variant has been previously reported as a compound heterozygous change in patients with hepatocerebral mitochondrial DNA depletion syndrome (PMID: 17694548) and has been classified as Likely Pathogenic by another clinical diagnostic laboratory in the ClinVar database (Variation ID: 38352). It is present in the heterozygous state in the gnomAD population database at a frequency of 0.002% (4/246258) and thus is presumed to be rare. In silico analyses support a deleterious effect of the c.263_265del (p.Lys88del) variant on protein function. Based on the available evidence, the c.263_265del (p.Lys88del) variant is classified as Likely Pathogenic. -
- -
Charcot-Marie-Tooth disease, axonal, type 2EE Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at